161 related articles for article (PubMed ID: 7640226)
1. Frequency of down-regulation of individual HLA-A and -B alleles in cervical carcinomas in relation to TAP-1 expression.
Keating PJ; Cromme FV; Duggan-Keen M; Snijders PJ; Walboomers JM; Hunter RD; Dyer PA; Stern PL
Br J Cancer; 1995 Aug; 72(2):405-11. PubMed ID: 7640226
[TBL] [Abstract][Full Text] [Related]
2. Differences in MHC and TAP-1 expression in cervical cancer lymph node metastases as compared with the primary tumours.
Cromme FV; van Bommel PF; Walboomers JM; Gallee MP; Stern PL; Kenemans P; Helmerhorst TJ; Stukart MJ; Meijer CJ
Br J Cancer; 1994 Jun; 69(6):1176-81. PubMed ID: 8198988
[TBL] [Abstract][Full Text] [Related]
3. Multiple genetic alterations cause frequent and heterogeneous human histocompatibility leukocyte antigen class I loss in cervical cancer.
Koopman LA; Corver WE; van der Slik AR; Giphart MJ; Fleuren GJ
J Exp Med; 2000 Mar; 191(6):961-76. PubMed ID: 10727458
[TBL] [Abstract][Full Text] [Related]
4. Loss of transporter protein, encoded by the TAP-1 gene, is highly correlated with loss of HLA expression in cervical carcinomas.
Cromme FV; Airey J; Heemels MT; Ploegh HL; Keating PJ; Stern PL; Meijer CJ; Walboomers JM
J Exp Med; 1994 Jan; 179(1):335-40. PubMed ID: 8270878
[TBL] [Abstract][Full Text] [Related]
5. Multiple mechanisms underlie HLA dysregulation in cervical cancer.
Brady CS; Bartholomew JS; Burt DJ; Duggan-Keen MF; Glenville S; Telford N; Little AM; Davidson JA; Jimenez P; Ruiz-Cabello F; Garrido F; Stern PL
Tissue Antigens; 2000 May; 55(5):401-11. PubMed ID: 10885560
[TBL] [Abstract][Full Text] [Related]
6. Loss of antigen-presenting molecules (MHC class I and TAP-1) in lung cancer.
Korkolopoulou P; Kaklamanis L; Pezzella F; Harris AL; Gatter KC
Br J Cancer; 1996 Jan; 73(2):148-53. PubMed ID: 8546899
[TBL] [Abstract][Full Text] [Related]
7. An immunohistochemical study of altered immunomodulatory molecule expression in head and neck squamous cell carcinoma.
Vora AR; Rodgers S; Parker AJ; Start R; Rees RC; Murray AK
Br J Cancer; 1997; 76(7):836-44. PubMed ID: 9328140
[TBL] [Abstract][Full Text] [Related]
8. TAP1, TAP2, and HLA-DR2 alleles are predictors of cervical cancer risk.
Gostout BS; Poland GA; Calhoun ES; Sohni YR; Giuntoli RL; McGovern RM; Sloan JA; Cha SS; Persing DH
Gynecol Oncol; 2003 Mar; 88(3):326-32. PubMed ID: 12648582
[TBL] [Abstract][Full Text] [Related]
9. Mutations in TAP genes are common in cervical carcinomas.
Fowler NL; Frazer IH
Gynecol Oncol; 2004 Mar; 92(3):914-21. PubMed ID: 14984960
[TBL] [Abstract][Full Text] [Related]
10. Down-regulation of HLA class I antigen in human papillomavirus type 16 E7 expressing HaCaT cells: correlate with TAP-1 expression.
Li W; Deng XM; Wang CX; Zhang X; Zheng GX; Zhang J; Feng JB
Int J Gynecol Cancer; 2010 Feb; 20(2):227-32. PubMed ID: 20134267
[TBL] [Abstract][Full Text] [Related]
11. Mutation in the beta 2m gene is not a frequent event in head and neck squamous cell carcinomas.
Feenstra M; Rozemuller E; Duran K; Stuy I; van den Tweel J; Slootweg P; de Weger R; Tilanus M
Hum Immunol; 1999 Aug; 60(8):697-706. PubMed ID: 10439315
[TBL] [Abstract][Full Text] [Related]
12. Antigen processing defects in cervical carcinomas limit the presentation of a CTL epitope from human papillomavirus 16 E6.
Evans M; Borysiewicz LK; Evans AS; Rowe M; Jones M; Gileadi U; Cerundolo V; Man S
J Immunol; 2001 Nov; 167(9):5420-8. PubMed ID: 11673561
[TBL] [Abstract][Full Text] [Related]
13. Association of antigen processing machinery and HLA class I defects with clinicopathological outcome in cervical carcinoma.
Mehta AM; Jordanova ES; Kenter GG; Ferrone S; Fleuren GJ
Cancer Immunol Immunother; 2008 Feb; 57(2):197-206. PubMed ID: 17622526
[TBL] [Abstract][Full Text] [Related]
14. Tumor escape from immune recognition: loss of HLA-A2 melanoma cell surface expression is associated with a complex rearrangement of the short arm of chromosome 6.
Maeurer MJ; Gollin SM; Storkus WJ; Swaney W; Karbach J; Martin D; Castelli C; Salter R; Knuth A; Lotze MT
Clin Cancer Res; 1996 Apr; 2(4):641-52. PubMed ID: 9816214
[TBL] [Abstract][Full Text] [Related]
15. Processing of a multiple membrane spanning Epstein-Barr virus protein for CD8(+) T cell recognition reveals a proteasome-dependent, transporter associated with antigen processing-independent pathway.
Lautscham G; Mayrhofer S; Taylor G; Haigh T; Leese A; Rickinson A; Blake N
J Exp Med; 2001 Oct; 194(8):1053-68. PubMed ID: 11602636
[TBL] [Abstract][Full Text] [Related]
16. Transporter associated with antigen processing preselection of peptides binding to the MHC: a bioinformatic evaluation.
Doytchinova I; Hemsley S; Flower DR
J Immunol; 2004 Dec; 173(11):6813-9. PubMed ID: 15557175
[TBL] [Abstract][Full Text] [Related]
17. Expression and genetic analysis of transporter associated with antigen processing in cervical carcinoma.
Vermeulen CF; Jordanova ES; ter Haar NT; Kolkman-Uljee SM; de Miranda NF; Ferrone S; Peters AA; Fleuren GJ
Gynecol Oncol; 2007 Jun; 105(3):593-9. PubMed ID: 17382375
[TBL] [Abstract][Full Text] [Related]
18. Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression.
Rowe M; Khanna R; Jacob CA; Argaet V; Kelly A; Powis S; Belich M; Croom-Carter D; Lee S; Burrows SR
Eur J Immunol; 1995 May; 25(5):1374-84. PubMed ID: 7774641
[TBL] [Abstract][Full Text] [Related]
19. Loss of MHC class-I expression in cervical carcinomas.
Connor ME; Stern PL
Int J Cancer; 1990 Dec; 46(6):1029-34. PubMed ID: 2174412
[TBL] [Abstract][Full Text] [Related]
20. Diversity of natural self-derived ligands presented by different HLA class I molecules in transporter antigen processing-deficient cells.
Lorente E; Infantes S; Barnea E; Beer I; Barriga A; García-Medel N; Lasala F; Jiménez M; Admon A; López D
PLoS One; 2013; 8(3):e59118. PubMed ID: 23555621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
